Think Investments’s Boston Scientific BSX Stock Holding History

Think Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-136,000	Closed	-$8.53M	–	25
2026 Q1	$8.53M	Buy	+136,000	New	+$10.9M	1.12%	30

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Think Investments's BSX Position: Q2 2026 in Review

Think Investments sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 136,000 shares — an estimated $8.53M sold.

Think Investments first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $8.53M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Think Investments reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Think Investments sold 136,000 Boston Scientific shares in Q2 2026, an estimated $8.53M.
Think Investments first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
Think Investments's Boston Scientific position peaked at $8.53M in Q1 2026.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Think Investments's 13F filing for Q2 2026, filed 14 Aug 2026.